Cite
Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID‐19 pandemic's impact on cancer diagnosis.
MLA
Negoita, Serban, et al. “Annual Report to the Nation on the Status of Cancer, Part 2: Early Assessment of the COVID‐19 Pandemic’s Impact on Cancer Diagnosis.” Cancer (0008543X), vol. 130, no. 1, Jan. 2024, pp. 117–27. EBSCOhost, https://doi.org/10.1002/cncr.35026.
APA
Negoita, S., Chen, H., Sanchez, P. V., Sherman, R. L., Henley, S. J., Siegel, R. L., Sung, H., Scott, S., Benard, V. B., Kohler, B. A., Jemal, A., & Cronin, K. A. (2024). Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID‐19 pandemic’s impact on cancer diagnosis. Cancer (0008543X), 130(1), 117–127. https://doi.org/10.1002/cncr.35026
Chicago
Negoita, Serban, Huann‐Sheng Chen, Pamela V. Sanchez, Recinda L. Sherman, S. Jane Henley, Rebecca L. Siegel, Hyuna Sung, et al. 2024. “Annual Report to the Nation on the Status of Cancer, Part 2: Early Assessment of the COVID‐19 Pandemic’s Impact on Cancer Diagnosis.” Cancer (0008543X) 130 (1): 117–27. doi:10.1002/cncr.35026.